Showing results (121-130 of 204) with videos related to

Sort By:
Pageof 21
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|November 27, 2023
First Trimester CD93 as a Novel Marker of Preeclampsia and Its Complications: A Pilot StudyFederica Piani, Giovanni Tossetta, Sonia Fantone, et al.
Chemico-Biological Interactions|February 1, 2024
Mechanisms of action of mineral fibres in a placental syncytiotrophoblast model: An in vitro toxicology studySonia Fantone, Giovanni Tossetta, Laura Cianfruglia, et al.
Journal of Clinical Pathology|July 11, 2006
Bicalutamide 50 mg monotherapy in patients with isolated high-grade PIN: findings in repeat biopsies at 6 monthsAldo V Bono, Roberta Mazzucchelli, Ilaria Ferrari, et al.
European Urology Oncology|September 5, 2020
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative ReviewAlessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, et al.
European Urology|May 13, 2008
Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomiesFrancesca Barbisan, Roberta Mazzucchelli, Alfredo Santinelli, et al.
IJU Case Reports|July 5, 2023
Clinical progression of megacalycosis in a girl with a solitary kidney: The lesson learnedAndrea Benedetto Galosi, Carlotta Nedbal, Vanessa Palantrani, et al.
BJU International|July 24, 2009
Secondary neoplasms of the urinary system and male genital organsDoriana Morichetti, Roberta Mazzucchelli, Antonio Lopez-Beltran, et al.
Translational Andrology and Urology|April 14, 2021
Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?Rodolfo Montironi, Liang Cheng, Alessia Cimadamore, et al.
Diagnostic Pathology|October 19, 2014
Does prostate acinar adenocarcinoma with Gleason Score 3+3=6 have the potential to metastasize?Rodolfo Montironi, Marina Scarpelli, Roberta Mazzucchelli, et al.
Cancers|July 24, 2021
Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker EvaluationAlessia Cimadamore, Roberta Mazzucchelli, Antonio Lopez-Beltran, et al.
Pageof 21